Hyaluronan-mediated motility receptor antisense RNA 1 promotes hepatitis B virus-related hepatocellular carcinoma progression by regulating miR-627-3p/High Mobility Group AT-hook 2 axis

References

• Mak LY, Cruz-Ramon V, Chinchilla-Lopez P, et al. Global epidemiology, prevention, and management of hepatocellular carcinoma[J]. Am Soc Clin Oncol Educ Book. 2018;38(38):262–279.
   PubMedGoogle Scholar
• Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol. 2019;16(10):589–604.
   PubMed Web of Science ®Google Scholar
• Wang CH, Wey KC, Mo LR, et al. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma[J]. Asian Pac J Cancer Prev. 2015;16(9):3595–3604.
   PubMedGoogle Scholar
• Ali A, Abdel-Hafiz H, Suhail M, et al. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma[J]. World J Gastroenterol. 2014;20(30):10238–10248.
   PubMed Web of Science ®Google Scholar
• Yang S, Liu Y, Feng X, et al. HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro[J]. Dig Liver Dis. 2021;53(3):360–366.
   PubMedGoogle Scholar
• Damania P, Sen B, Dar SB, et al. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein 4 (PDCD4) and phosphatase and tensin homologue (PTEN)[J]. PLoS One. 2014;9(3):e91745.
   PubMed Web of Science ®Google Scholar
• Sartorius K, Swadling L, An P, et al. The multiple roles of Hepatitis B Virus X Protein (HBx) dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and immune pathways[J]. Viruses. 2020;12(7):746.
   PubMed Web of Science ®Google Scholar
• He B, Peng F, Li W, et al. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling[J]. J Cell Biochem. 2019;120(3):2908–2918.
   PubMed Web of Science ®Google Scholar
• Shi T, Hua Q, Ma Z, et al. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma[J]. Pathol Res Pract. 2017;213(12):1464–1469.
   PubMed Web of Science ®Google Scholar
• Andersen GB, Tost J. Circulating miRNAs as biomarker in cancer[J]. Recent Results Cancer Res. 2020;215:277–298.
   PubMedGoogle Scholar
• Alamoudi AA, Alnoury A, Gad H. miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming[J]. Brief Funct Genomics. 2018;17(3):157–169.
   PubMed Web of Science ®Google Scholar
• Terkelsen T, Russo F, Gromov P, et al. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration[J]. Breast Cancer Res. 2020;22(1):73.
   PubMed Web of Science ®Google Scholar
• Zedan AH, Hansen TF, Assenholt J, et al. microRNA expression in tumour tissue and plasma in patients with newly diagnosed metastatic prostate cancer[J]. Tumour Biol. 2018;40(5):1010428318775864.
   Google Scholar
• Lei Z, Wentao Z, Guanxi W, et al. Investigation of microRNA expression signatures in HCC via microRNA gene chip and bioinformatics analysis[J]. Pathol Res Pract. 2020;216(6):152982.
   PubMed Web of Science ®Google Scholar
• HE M, Peng S, Chuang Q, et al. MiR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN[J]. Aging (Albany NY). 2019;11(15):5744–5756.
   PubMedGoogle Scholar
• Dan L, Li W, Jin F, et al. RP11-284F21.9 promotes lung carcinoma proliferation and invasion via the regulation of miR-627-3p/CCAR1[J]. Oncol Rep. 2020;44(4):1638–1648.
   PubMed Web of Science ®Google Scholar
• Hongfu L, Juan L, Huali Z, et al. DNAJC2 is reversely regulated by miR-627-3p, promoting the proliferation of colorectal cancer[J]. Mol Med Rep. 2021;24(2):589.
   PubMed Web of Science ®Google Scholar
• Meng L, Zheng Y, Liu S, et al. ZEB1 represses biogenesis of circ-DOCK5 to facilitate metastasis in esophageal squamous cell carcinoma via a positive feedback loop with TGF-β[J]. Cancer Lett. 2021;519:117–129.
   PubMed Web of Science ®Google Scholar
• Chandra Gupta S, Nandan Tripathi Y. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140(9):1955–1967.
   PubMed Web of Science ®Google Scholar
• Cai Y, Sheng Z, Chen Y, et al. LncRNA HMMR-AS1 promotes proliferation and metastasis of lung adenocarcinoma by regulating MiR-138/sirt6 axis[J]. Aging (Albany NY). 2019;11(10):3041–3054.
   PubMedGoogle Scholar
• Chu ZP, Dai J, Jia LG, et al. Increased expression of long noncoding RNA HMMR-AS1 in epithelial ovarian cancer: an independent prognostic factor[J]. Eur Rev Med Pharmacol Sci. 2018;22(23):8145–8150.
   PubMed Web of Science ®Google Scholar
• Li J, Ji X, Wang H. Targeting long noncoding RNA HMMR-AS1 suppresses and radiosensitizes glioblastoma[J]. Neoplasia. 2018;20(5):456–466.
   PubMed Web of Science ®Google Scholar
• Liu W, Ma J, Cheng Y, et al. HMMR antisense RNA 1, a novel long noncoding RNA, regulates the progression of basal-like breast cancer cells[J]. Breast Cancer (Dove Med Press). 2016;8:223–229.
   PubMed Web of Science ®Google Scholar
• Ramnarine VR, Kobelev M, Gibb EA, et al. The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management[J]. Eur Urol. 2019;76(5):546–559.
   PubMed Web of Science ®Google Scholar
• Zhang X, Hong R, Chen W, et al. The role of long noncoding RNA in major human disease[J]. Bioorg Chem. 2019;92:103214.
   PubMed Web of Science ®Google Scholar
• Ghosh A, Platt RN 2nd, Vandewege MW, et al. Identification and characterization of microRNAs (miRNAs) and their transposable element origins in the saltwater crocodile, Crocodylus porosus[J]. Anal Biochem. 2020;602:113781.
   PubMed Web of Science ®Google Scholar
• Ratti M, Lampis A, Ghidini M, et al. MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside[J]. Target Oncol. 2020;15(3):261–278.
   PubMed Web of Science ®Google Scholar
• Duan Y, Zhao M, Jiang M, et al. LINC02476 promotes the malignant phenotype of hepatocellular carcinoma by sponging miR-497 and Increasing HMGA2 expression[J]. Onco Targets Ther. 2020;13:2701–2710.
   PubMed Web of Science ®Google Scholar
• Wu S, Ai H, Zhang K, et al. Long non-coding RNA EGOT promotes the malignant phenotypes of hepatocellular carcinoma cells and increases the expression of HMGA2 via down-regulating miR-33a-5p[J]. Onco Targets Ther. 2019;12:11623–11635.
   PubMed Web of Science ®Google Scholar
• Zheng H, Bi FR, Yang Y, et al. Downregulation of miR-196-5p induced by hypoxia drives tumorigenesis and metastasis in hepatocellular carcinoma[J]. Horm Cancer. 2019;10(4–6):177–189.
   PubMed Web of Science ®Google Scholar
• Li S, Peng F, Ning Y, et al. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma[J]. J Cell Biochem. 2020;121(3):2543–2558.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Zhou J, Zhang C, et al. Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis. Braz J Med Biol Res. 2018;51(7):e7220.
   PubMed Web of Science ®Google Scholar
• Zha Y, Yao Q, Liu JS, et al. Hepatitis B virus X protein promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cell line HCCLM3 by targeting HMGA2. Oncol Lett. 2018;16(5):5709–5714.
   PubMed Web of Science ®Google Scholar